Instructor in Medicine, Dana-Farber Cancer Institute
Hematology
Dr. Brett Glotzbecker, MD
|
|
Give Review
Brett Glotzbecker is an expert in the field of Hematology. She studied medicine at Perelman School of Medicine at the University of Pennsylvania. Brett Glotzbecker is a published doctor. She has 16 papers published. The most current publication "Hematopoietic Cell Transplantation in Patients with Medication-Related Osteonecrosis of the Jaws."
Publications
- A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A P...
- The Utility of Routine Chest Radiography in the Initial Evaluation of Adult Patients With Febrile Neutropenia Patients Undergoing HSCT.
- Risk Factors for Readmission after Allogeneic Hematopoietic Stem Cell Transplantation and Impact on Overall Survival.
- Donor Chimerism Early after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation Predicts Relapse and Survival.
- Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem Cell transplantation for hematologic malignancies.
- Prostaglandin-modulated umbilical cord blood hematopoietic stem Cell transplantation.
- Low levels of 25-hydroxyvitamin D before allogeneic hematopoietic SCT correlate with the development of chronic GVHD.
- A Phase I Study of Alemtuzumab for Therapy of Steroid-Refractory Chronic Graft-versus-Host Disease.
- Hepatic veno-occlusive Disease after hematopoietic stem cell transplantation: novel insights to pathogenesis, current status of treatment, and future directions.
- Lenalidomide enhances anti-myeloma Cellular immunity.
- Important drug interactions in hematopoietic stem Cell transplantation: what every physician should know.
- Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation.
- PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-Cell responses to autologous dendritic Cell/myeloma fusion vaccine.
- Immunomodulatory effects of vitamin D: implications for GVHD.
- Hematopoietic Cell Transplantation in Patients with Medication-Related Osteonecrosis of the Jaws.
Schools
University Of Pennsylvania School Of Medicine
Beth Israel Deaconess Med Center
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Burkitt's Lymphoma
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Beth Israel Deaconess Medical Center -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
Brigham and Women's Hospital -
Massachusetts General Hospital -
Dana-Farber Cancer Institute
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1649248899 |
| Last Name Of The Provider | GLOTZBECKER |
| First Name Of The Provider | BRETT |
| View All |
Similar Doctors
|
|
Dr. Mark S. Stonecypher, MD |
|
|
Michael P. Tobin, MT
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Meghan E. Shea, MD |
|
|
Dr. John M. Gansner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nishan Tchekmedyian, MD |
|
|
Dr. Wendy Y. Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Dorfman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeremy Warner, MD |
|
|
Dr. Matthew VanDerheiden, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Einstein, MD |